MSA
REGN icon

MUFG Securities Americas’s Regeneron Pharmaceuticals REGN Stock Holding History

MUFG Securities Americas’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Buy
3,010
+221
+8% +$150K 0.1% 191
2026
Q1 		$2.15M Buy
2,789
+74
+3% +$56.7K 0.14% 136
2025
Q4 		$2.1M Sell
2,715
-33
-1% -$22.4K 0.13% 137
2025
Q3 		$1.55M Buy
2,748
+447
+19% +$253K 0.1% 181
2025
Q2 		$1.21M Buy
2,301
+439
+24% +$245K 0.1% 179
2025
Q1 		$1.18M Buy
1,862
+308
+20% +$212K 0.14% 143
2024
Q4 		$1.11M Buy
+1,554
New +$1.3M 0.14% 134

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

MUFG Securities Americas's REGN Position: Q2 2026 in Review

MUFG Securities Americas increased its Regeneron Pharmaceuticals (REGN) stake by 7.9% in Q2 2026, buying an estimated $150K and bringing the position to 3,010 shares worth $1.88M. The position accounts for 0.1% of the portfolio, ranked #191.

MUFG Securities Americas first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.15M in Q1 2026. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • MUFG Securities Americas held 3,010 shares of Regeneron Pharmaceuticals worth $1.88M as of Q2 2026.
  • MUFG Securities Americas bought 221 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $150K.
  • Regeneron Pharmaceuticals made up 0.1% of MUFG Securities Americas's portfolio in Q2 2026, its #191 holding.
  • MUFG Securities Americas first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • MUFG Securities Americas's Regeneron Pharmaceuticals position peaked at $2.15M in Q1 2026.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.